What is the recommended treatment for pediatric pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Pediatric Pneumonia

The recommended first-line treatment for pediatric community-acquired pneumonia is oral amoxicillin at 90 mg/kg/day in 2 doses for children with presumed bacterial pneumonia, and azithromycin for children with presumed atypical pneumonia. 1

Age-Based Treatment Recommendations

Outpatient Management

  • For children under 5 years with presumed bacterial pneumonia:

    • Oral amoxicillin 90 mg/kg/day in 2 doses 2, 1
    • Alternative: amoxicillin-clavulanate (amoxicillin component 90 mg/kg/day in 2 doses) 2
  • For children under 5 years with presumed atypical pneumonia:

    • Oral azithromycin 10 mg/kg on day 1, followed by 5 mg/kg/day once daily on days 2-5 2, 1, 3
    • Alternatives: clarithromycin (15 mg/kg/day in 2 doses) or erythromycin (40 mg/kg/day in 4 doses) 2
  • For children 5 years and older with presumed bacterial pneumonia:

    • Oral amoxicillin 90 mg/kg/day in 2 doses (maximum 4 g/day) 2, 1
    • For children with presumed bacterial CAP who don't have clear distinction from atypical CAP, a macrolide can be added to a β-lactam antibiotic 2
  • For children 5 years and older with presumed atypical pneumonia:

    • Oral azithromycin 10 mg/kg on day 1, followed by 5 mg/kg/day once daily on days 2-5 (maximum 500 mg on day 1, followed by 250 mg on days 2-5) 2, 1, 3
    • Alternatives for children >7 years: doxycycline (2-4 mg/kg/day in 2 doses) 2, 1

Inpatient Management

  • For fully immunized children with no risk factors for resistant organisms:

    • Ampicillin or penicillin G 2, 4
    • Add azithromycin if atypical pneumonia is suspected 2, 4
  • For children not fully immunized or in areas with high prevalence of resistant pneumococci:

    • Ceftriaxone (50-100 mg/kg/day every 12-24 hours) or cefotaxime (150 mg/kg/day every 8 hours) 2, 4
    • Add vancomycin or clindamycin if MRSA is suspected 2, 4

Pathogen-Specific Considerations

  • For Streptococcus pneumoniae:

    • Oral: amoxicillin (90 mg/kg/day in 2 doses) 2, 1
    • Parenteral: penicillin (100,000-250,000 U/kg/day every 4-6 hours) or ampicillin (200 mg/kg/day every 6 hours) 2
    • Alternatives: ceftriaxone or cefotaxime 2
  • For Mycoplasma pneumoniae or Chlamydophila pneumoniae:

    • Oral: azithromycin (10 mg/kg on day 1, followed by 5 mg/kg/day once daily on days 2-5) 2, 1
    • Parenteral: IV azithromycin (10 mg/kg on days 1 and 2) 2
  • For Staphylococcus aureus (methicillin-susceptible):

    • Oral: cephalexin (75-100 mg/kg/day in 3-4 doses) 2
    • Parenteral: cefazolin (150 mg/kg/day every 8 hours) or oxacillin (150-200 mg/kg/day every 6-8 hours) 2, 5
  • For MRSA (clindamycin-susceptible):

    • Oral: clindamycin (30-40 mg/kg/day in 3-4 doses) 2
    • Parenteral: vancomycin (40-60 mg/kg/day every 6-8 hours) or clindamycin (40 mg/kg/day every 6-8 hours) 2

Duration of Treatment

  • For uncomplicated pneumonia: 5-7 days of antibiotics is typically adequate 2, 6
  • For pneumonia with parapneumonic effusion: 2-4 weeks of antibiotics, depending on drainage adequacy and clinical response 2
  • For complicated pneumonia: prolonged course of IV antibiotics followed by oral antibiotics 7

Management of Parapneumonic Effusions

  • Small effusions (<10mm rim): treat with antibiotics alone, no drainage needed unless respiratory compromise is high 2
  • Moderate to large effusions: consider drainage options based on respiratory compromise 2:
    • Chest tube alone
    • Chest tube with fibrinolytics (preferred initial approach)
    • Video-assisted thoracoscopic surgery (VATS) if not responding to fibrinolytics (approximately 15% of patients) 2

Assessment of Treatment Response

  • Patients should show clinical improvement within 48-72 hours of starting appropriate antibiotics 2, 1
  • If no improvement after 48-72 hours, consider 2:
    • Clinical and laboratory reassessment for disease severity
    • Further imaging (ultrasound or CT) to assess for complications
    • Investigation for resistant pathogens or secondary infections
    • For mechanically ventilated children, obtain BAL specimen for Gram stain and culture 2

Discharge Criteria

  • Documented overall clinical improvement including level of activity, appetite, and decreased fever for at least 12-24 hours 2
  • Consistent pulse oximetry measurements >90% in room air for at least 12-24 hours 2

Common Pitfalls to Avoid

  • Underdosing amoxicillin: Using standard doses (40-45 mg/kg/day) rather than the recommended higher doses (90 mg/kg/day) for pneumonia may lead to treatment failure due to resistant pneumococci 1
  • Inappropriate use of macrolides as first-line therapy for presumed bacterial pneumonia in young children 1, 8
  • Failure to reassess children not improving within 48-72 hours 2, 1
  • Routine chest radiographs at the end of therapy are not recommended unless clinically indicated 6
  • Overlooking the possibility of complications (empyema, lung abscess) in children not responding to appropriate therapy 6, 7

References

Guideline

First-Line Antibiotic Recommendations for Pediatric Outpatients with Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Regimens for Community-Acquired Pneumonia in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Maximum Recommended Dose of Cefazolin for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Complicated pneumonia in children.

Lancet (London, England), 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.